Antiretroviral therapy coverage in Libya
Libya: Antiretroviral therapy coverage was 50.0% in 2023. ▲ Rising
Antiretroviral therapy coverage in Libya, 2000–2023
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Libya is 50.0%, measured in 2023.
Compared with earlier readings it is up 6.4% on the previous year and down 2.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Libya peaked at 68.0% in 2018 and was at its lowest, 12.0%, in 2000.
Libya ranks 120th of 143 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Antiretroviral therapy coverage in Libya, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 12.0% | — |
| 2001 | 13.0% | +8.3% |
| 2002 | 15.0% | +15.4% |
| 2003 | 13.0% | -13.3% |
| 2004 | 18.0% | +38.5% |
| 2005 | 20.0% | +11.1% |
| 2006 | 23.0% | +15.0% |
| 2007 | 27.0% | +17.4% |
| 2008 | 32.0% | +18.5% |
| 2009 | 38.0% | +18.8% |
| 2010 | 44.0% | +15.8% |
| 2011 | 50.0% | +13.6% |
| 2012 | 52.0% | +4.0% |
| 2013 | 51.0% | -1.9% |
| 2014 | 55.0% | +7.8% |
| 2015 | 59.0% | +7.3% |
| 2016 | 61.0% | +3.4% |
| 2017 | 62.0% | +1.6% |
| 2018 | 68.0% | +9.7% |
| 2019 | 53.0% | -22.1% |
| 2020 | 50.0% | -5.7% |
| 2021 | 49.0% | -2.0% |
| 2022 | 47.0% | -4.1% |
| 2023 | 50.0% | +6.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 21.1% | 12.0% | 38.0% | 10 |
| 2010s | 55.5% | 44.0% | 68.0% | 10 |
| 2020s | 49.0% | 47.0% | 50.0% | 4 |
Countries ranked near Libya
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Population ages 15-19, male, annual growth rate 1.2 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0473 units per person (2025)
- Population ages 20-24, female, annual growth rate 2.62 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0406 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Libya?
- Antiretroviral therapy coverage in Libya was 50.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Libya?
- The highest recorded value was 68.0% in 2018.
- What is the lowest antiretroviral therapy coverage recorded in Libya?
- The lowest recorded value was 12.0% in 2000.
- How does Libya rank for antiretroviral therapy coverage?
- Libya ranks 120th out of 143 countries with data for 2023.
- Is antiretroviral therapy coverage rising or falling in Libya?
- Over the last ten years it is down 2.0%. The long-run trend across the full record is rising.
- Where does this Libya data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.